Latest News
A new study examines the catalytic activity of PrimPol and effects of HIV+ patients on tenofovir-based Anti-Retroviral Therapy (ART) with mitochondrial toxicity.
- July 10, 2020
Zhengxin (Jason) Cai, PhD, Assistant Professor, Yale University PET Center, has received a R21 NIH/National Cancer Institute grant to develop novel PET imaging agents for CXCR5, a biomarker and potential treatment target for Angioimmunoblastic T-cell lymphoma (AITL)
- July 10, 2020
Marcella Nunez-Smith, MD, MHS, has been appointed Director of the Center for Community Engagement and Health Equity for Yale Cancer Center and Smilow Cancer Hospital, as well as Chief Health Equity Officer & Deputy Chief Medical Officer, at Smilow Cancer Hospital, and Associate Cancer Center Director for Community Outreach and Engagement at Yale Cancer Center.
- July 09, 2020Source: Washington Post
It will be impossible for students working from their home countries to keep up. I’ve tried.
- July 09, 2020Source: YaleNews
A “falls care manager” worked with the patients and their physicians to identify risk factors for falls and fall-related injuries. The falls care managers also created care plans to reduce these risk factors.
- July 09, 2020
Clinical Science Award for Oral Presentation from ESHRE
- July 09, 2020
For many of the women who are scheduling the screening mammograms that were deferred in the spring, their health care decisions are being guided in part by knowledge gleaned from 10 years of dense breast notification laws.
- July 09, 2020Source: Anderson Cooper 360
Study: half of COVID-19 cases may be caused by "silent spreaders"
- July 09, 2020Source: Condé Nast Traveler
Three health experts weigh in.
- July 09, 2020Source: Yale Medicine Magazine
The stories in this issue look at research that sheds light on previously dark corners of the brain including mechanisms responsible for or connected to Alzheimer’s Disease, epilepsy, and schizophrenia, and imperfectly understood activities including sleep and thought.
